Compound ID | 491
REP 6021
Class: Small molecule antibacterial agent
| Agent Type: | Direct acting; |
| Spectrum of activity: | Gram-positive & Gram-negative |
| Mechanism of action: | DNA synthesis inhibitor. DNA polymerase III inhibitor |
| Institute where first reported: | GSK, USA; Replidyne, Inc., (Cardiovascular Systems, Inc, USA) |
| Year first mentioned: | 2004 |
| Development status: | Experimental |
| Reason dropped: | Replidyne suspended development of this compound due to need of additional investment |
| External links: |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.